Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Johnson Pharmacare has informed that a meeting of the Board of Directors of the Company will be held on Monday 25th July 2022 to consider following business: To approve and take on record the Un-Audited Financial Results of the Company for the quarter ended on 30th June 2022 and Any other matter with the permission of the board which the Board may think fit.
The above information is a part of company’s filings submitted to BSE.
